Login

James P. Scriven, CEO of IDB Invest, shares insights on Latin American finance and development with the International Finance Corporation. 00:10:00

Share On Facebook Share On Twitter

James P. Scriven, CEO of IDB Invest

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Dan Dolan Discusses the Evolution and Impact of Select Sector SPDR ETFs
00:10:00
Fund established by operators for operators|Arielle Zuckerberg,General Partner,Long Journey Ventures
00:10:00
Protecting Your Retirement: Essential Steps After a Layoff | Lindsay Adams, Advisor, CGN Advisors, LLC.
00:10:00
Focus companies that can get to market with very little capital|Cat Dizon,Co-Founder and COO,Active Capital
00:10:00
Market Challenges and Investment Strategies with Hilltop’s CEO Derek Kelly | Derek Kelly, CEO, Hilltop Financial Planning.
00:10:00
Tailwind is focused on control investments in high quality, middle market companies|Caroline Adams,Vp,Tailwind Management LP
00:10:00
Exploring Mining Innovation: A Conversation with NSS Canada's Bruno Lalonde | Bruno Lalonde - CEO/President of NSS Canada
00:10:00
Orbis' CEO Jani Linna-Aro interviews Phil Stanway from Huber+Suhner AG about their partnership and business insights.
00:10:00
Future of Asset Management: Insights from Industry Leaders
00:10:00
Journey of a Trailblazer: Gene's Path from Administrative Assistant to CEO of Wellington | Jean Hynes , CEO , Wellington Management.
00:10:00
Interview with Doug Gruer, CEO of Emu NL on Assay TV
00:00:00
Harry Fleming, CEO, Nobilis Health Corp

© 2026 Nehu